Glenmede Trust’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,558
| Closed | -$18K | – | 1357 |
|
|
2022
Q3 | $18K | Buy |
+11,558
| New | +$18K | ﹤0.01% | 1225 |
|
|
2021
Q1 | – | Sell |
-29,257
| Closed | -$199K | – | 1270 |
|
|
2020
Q4 | $199K | Buy |
29,257
+122
| +0.4% | +$830 | ﹤0.01% | 1062 |
|
|
2020
Q3 | $324K | Sell |
29,135
-200
| -0.7% | -$2.22K | ﹤0.01% | 900 |
|
|
2020
Q2 | $184K | Buy |
29,335
+200
| +0.7% | +$1.25K | ﹤0.01% | 1031 |
|
|
2020
Q1 | $98K | Hold |
29,135
| – | – | ﹤0.01% | 1428 |
|
|
2019
Q4 | $98K | Hold |
29,135
| – | – | ﹤0.01% | 1428 |
|
|
2019
Q3 | $62 | Hold |
29,135
| – | – | ﹤0.01% | 1561 |
|
|
2019
Q2 | $77 | Hold |
29,135
| – | – | ﹤0.01% | 1497 |
|
|
2019
Q1 | $138 | Hold |
29,135
| – | – | ﹤0.01% | 1309 |
|
|
2018
Q4 | $69 | Hold |
29,135
| – | – | ﹤0.01% | 1464 |
|
|
2018
Q3 | $128K | Hold |
29,135
| – | – | ﹤0.01% | 1257 |
|
|
2018
Q2 | $210K | Hold |
29,135
| – | – | ﹤0.01% | 1053 |
|
|
2018
Q1 | $110K | Hold |
29,135
| – | – | ﹤0.01% | 1370 |
|
|
2017
Q4 | $110K | Hold |
29,135
| – | – | ﹤0.01% | 1370 |
|
|
2017
Q3 | $49K | Hold |
29,135
| – | – | ﹤0.01% | 1659 |
|
|
2017
Q2 | $115K | Hold |
29,135
| – | – | ﹤0.01% | 1346 |
|
|
2017
Q1 | $115K | Hold |
29,135
| – | – | ﹤0.01% | 1346 |
|
|
2016
Q4 | $142K | Hold |
29,135
| – | – | ﹤0.01% | 1298 |
|
|
2016
Q3 | $225K | Hold |
29,135
| – | – | ﹤0.01% | 1163 |
|
|
2016
Q2 | $163K | Hold |
29,135
| – | – | ﹤0.01% | 1234 |
|
|
2016
Q1 | $156K | Hold |
29,135
| – | – | ﹤0.01% | 1227 |
|
|
2015
Q4 | $253K | Hold |
29,135
| – | – | ﹤0.01% | 1113 |
|
|
2015
Q3 | $244K | Buy |
+29,135
| New | +$244K | ﹤0.01% | 1130 |
|